This site is intended for health professionals only
Sunday 16 June 2019
Share |

J&J asks judge to dismiss case

Pharmaceutical giant Johnson & Johnson has asked a federal judge in the US to dismiss a complaint about the company regarding it paying millions of dollars in kickabouts to promote the use of its popular schizophrenia medication.

According to two whistleblowers and the US government, J&J paid vast sums of money to Omnicare Inc, for its pharmacists to recommend the use of Risperdal.

The drug was widely used to treat patients showing signs of Alzheimer's.

But an investigation into the drug later found that it had a direct link to the increase in deaths among Alzheimer's patients.

J&J, based in New Brunswick, argued discounts such as those it gave Omnicare were standard industry practice and did not violate the federal anti-kickback law or similar state laws as long as discounts were properly disclosed.

"It is absolutely clear that there is nothing unreasonable about the interpretation Johnson & Johnson had of the statute," said William Sarraille, an attorney for the company.

Copyright Press Association 2010


Ads by Google

You are leaving

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?


Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.



Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher